1 / 41

Disorders of aromatic amino acid metabolism (Phenylalanine, tyrosine)

Disorders of aromatic amino acid metabolism (Phenylalanine, tyrosine). Dr. Ketki K Assistant Professor Department of Biochemistry. Inborn error of Phenylalanine & tyrosine metabolism (IEM). IEM. Cause: Mutant genes results in Abnormal enzyme/

avilar
Download Presentation

Disorders of aromatic amino acid metabolism (Phenylalanine, tyrosine)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Disorders of aromatic amino acid metabolism(Phenylalanine, tyrosine) Dr. Ketki KAssistant Professor Department of Biochemistry

  2. Inborn error of Phenylalanine & tyrosine metabolism (IEM)

  3. IEM • Cause: Mutant genes results in • Abnormal enzyme/ • Total loss of enzyme activity/ • Partial deficiency of enzyme • Further leads to accumulation of substrate & • No product formation

  4. IEM of Phe & Tyr • Phenylketonuria (PKU) • Alkaptonuria • Tyrosinemia • Albinism

  5. PKU • Most common IEM, Autosomal Recessive • Incidence- 1: 10,000 • Types: • Type I- Classical: deficiency of Phenylalanine hydroxylase • Type II & III: deficiency of Dihydro biopterin reducase • Type IV & V : deficiency of enzyme synthesizing biopterin

  6. Step 1: Phenylalanine to tyrosine • Phenylalanine hydroxylase ,1 -A) NADPH dependant reductase

  7. BH4 required for • Phenylalanine hydroxylase = synthesis of tyrosine • tyrosine hydroxylase = synthesis of catecholamines(NT) • tryptophan hydroxylase = synthesis of Serotonin • Deficiency of BH4 leads to ↓ tyrosine, dopamine,serotonin in brain

  8. Consequences/biochemical abnormalities

  9. 1) Hyperphenylalaninemia (>20 mg/dL) ↑ phenylalnine in tissue, plasma,urine 2)↑phenyllactate,phenylacetate,phenylpyruvate excreted in urine • These metabolites give urine : "mousy" odor.

  10. C/F • Mental Retardation (low IQ<50),intellectual disability (low IQ),developmental delay, microcephaly, hyperactivity,seizures,agitation • Hypopigmentation (elevated phenylalanine competitively inhibits tyrosinase & impairs melanin formation) that causes light skin color,fair hair, blue eyes etc • Mousy body odor (due to presence of phenyllactic acid in sweat)

  11. Laboratory diagnosis & screening • Blood phenylalanine: Normal level 1 mg/dL In PKU, level > 20 mg/dL diagnosed by chromatography, Tandem mass spectrometry (TMS) Time of blood collection in new born: 24-48 hrs after protein feeding/breast feeding (to avoid false negative results)

  12. 2) Ferric chloride test in urine: blue-green 3) Guthrie’s test: blood/urine: b. subtilis 4) DNPH test in urine : Yellow ppt 5) HPLC: High performance liquid chromatography 6) Prenatal diagnosis by using : cultured amniotic cells

  13. Treatment 1) Diet low in phenylalanine (tapioca/cassava)/ synthetic amino acid preparation free of phenylalanine supplemented with some natural foods (fruits,vegetables, cereals) selected for their low phenylalanine content • Treatment must begin during first 7-10 days of life to prevent neurological impairment • Lifelong restriction of phenylalanine is recommended

  14. 2) supply tyrosine In diet 3) supplementation with BH4 , L-3,4-dihydroxyphenylalnine(L-DOPA) & 5- hydroxytryptophan Improves clinical outcome in type II,III.IV, v PKU

  15. Maternal PKU: • Lady having PKU,but not on low Phe diet becomes pregnant • Then the offspring develops “Maternal PKU syndrome”. • It causes microcephaly & congenital heart abnormalities in fetus. • It can be prevented by dietary restriction of phenylalanine in mother prior to pregnancy & maintain throughout pregnancy

  16. Alkaptonuria • Autosomal recessive, incidence 1 in 2,50,000 births • Metabolic defect: Deficiency of Homogentisic acid oxidase • Consequences: increased homogentisic acid in urine

  17. Biochemical manifestation

  18. C/F: Patient may be asymptomatic until age 40 • Urine gets darken on exposure to air • Dark staining of diapers indicate disease in infants • Large joint arthritis, Ochronosis (deposition of black pigment/alkapton bodies on cartilage & collagenous tissue)

  19. Investigations: • Urine: black on standing • Ferric chloride test in urine: green color • Benedict’s test in urine: orange-red color • Silver nitrate test in urine: Black ppt • HPLC

  20. Treatment: • Not life threatening condition so no specific treatment required • Diet low in phenylalanine & tyrosine

  21. Albinism • Autosomal recessive, Incidence: 1 in 20,000 • Due to deficiency in synthesis of pigment melanin which is due to absence of tyrosinase (copper containing enzyme) in eye & skin [ c/a tyrosinase negative oculocutaneous albinism ]

  22. Hypopigmentation of skin, fundus & iris • Associated Photophobia,nystagmus,↓ visual acuity • Skin sensitivity to sunlight, prone to skin cancer(melanoma)

  23. Tyrosinemia 1)Type I Tyrosinemia: Hepatorenal -Tyrosinemia 2) Type II Tyrosinemia: Oculocutaneous- Tyrosinemia 3) Type III Tyrosinemia : Neonatal Tyrosinemia 4) Hawkinsinuria

  24. 1)Type I Tyrosinemia: Hepatorenal -Tyrosinemia • Also c/a tyrosinosis • AR • Incidence: 1.5 per 1,000 births • Cause: def of Fumaryl acetoacetate hydrolase

  25. C/F: Cabbage like odor Hypoglycemia Liver failure, renal tubular dysfunction Vitamin D resistant rickets Mild Mental Retardation, Death may occur in first 6 months of life

  26. Investigation: • Urine contains tyrosine, pHPPA,hydroxyphenyllactic acid • Serum: shows tyrosine • Treatment: • Tyrosine & phenylalanine restricted diet

  27. Type II Tyrosinemia: Oculocutaneous- Tyrosinemia • C/a Richner-Hanhart syndrome • Cause: deficiency of tyrosine transaminase • Consequences : urinary excretion of tyrosine,tyramine • C/F: Mental retardation, dermatitis, palmoplantar keratosis, photophobia • Treatment: diet low in phe,tyr

  28. Type III Tyrosinemia : Neonatal Tyrosinemia Due to def of p-hydroxy phenylpyruvate hydroxylase Temporary condition Overcome by treatment with ascorbic acid

  29. Hawkinsinuria • Autosomal dominant • Due to def of p-HPPA oxidase • Excretion of p-HPPA in urine

  30. Case 1 • 2 weeks infant: convulsions, mousy odor in urine, • Ferric chloride test; green

  31. Plasma phenylalanine ↑increased • Urine Phenylalanine, Phenylpyruvate, Phenyllactate ↑

  32. What is the defect? • Why convulsions? • Why fair skin? • What is the importance of early diagnosis?

  33. Case 2 • 3 yrs child is having white hair + fair skin • addition of THB had no effect • What is the biochemical defect? • Will there be any abnormality of catecholamine metabolism?

  34. Case 3 • Mother of 1.5 year old child came with complaint of progressive appearance of hyperchromic papules on his second fingers of both hands since 1 year. he also had darkening of urine & diaper. • What is the diagnosis?

  35. "Once you start a working on something,don't be afraid of failure and don't abandon it. People who work sincerely are the happiest." Chanakya quotes (Indian politician, strategist and writer, 350 BC-275BC)  

More Related